Entering text into the input field will update the search result below

MyMD to collaborate with leading U.S. eye hospital Bascom on a pre-clinical study

Jul. 12, 2022 10:30 AM ETMyMD Pharmaceuticals, Inc. (MYMD)By: Anuron Mitra, SA News Editor

Human eye


  • MyMD Pharmaceuticals (NASDAQ:MYMD) on Tuesday said it would collaborate with an eye hospital in Florida on a pre-clinical study with its drug candidate MYMD-1 for the treatment of traumatic optic neuropathy (TON).
  • TON is a condition caused by injury to the optic nerve in the eye which results in vision loss.
  • MYMD said it would be collaborating with Bascom Palmer Eye Institute, a leading eye hospital based in Miami, Florida.
  • The project will be entirely funded by Bascom.
  • MYMD stock +0.9% to $4.31 in morning trading.

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About MYMD

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
MyMD Pharmaceuticals, Inc.
Lexaria Bioscience Corp.
Onconova Therapeutics, Inc.
Aytu BioPharma, Inc.
Cocrystal Pharma, Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.